{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T22:09:30Z","timestamp":1792447770735,"version":"4.5.0"},"reference-count":103,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T00:00:00Z","timestamp":1671062400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T00:00:00Z","timestamp":1671062400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Patients with end-stage kidney disease (ESKD) are at high risk of severe COVID-19. Here, we perform longitudinal blood sampling of ESKD haemodialysis patients with COVID-19, collecting samples pre-infection, serially during infection, and after clinical recovery. Using plasma proteomics, and RNA-sequencing and flow cytometry of immune cells, we identify transcriptomic and proteomic signatures of COVID-19 severity, and find distinct temporal molecular profiles in patients with severe disease. Supervised learning reveals that the plasma proteome is a superior indicator of clinical severity than the PBMC transcriptome. We show that a decreasing trajectory of plasma LRRC15, a proposed co-receptor for SARS-CoV-2, is associated with a more severe clinical course. We observe that two months after the acute infection, patients still display dysregulated gene expression related to vascular, platelet and coagulation pathways, including <jats:italic>PF4<\/jats:italic> (platelet factor 4), which may explain the prolonged thrombotic risk following COVID-19.<\/jats:p>","DOI":"10.1038\/s41467-022-35454-4","type":"journal-article","created":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T16:10:39Z","timestamp":1671120639000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Multi-omics identify falling LRRC15 as a COVID-19 severity marker and persistent pro-thrombotic signals in convalescence"],"prefix":"10.1038","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0511-8123","authenticated-orcid":false,"given":"Jack S.","family":"Gisby","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4897-5379","authenticated-orcid":false,"given":"Norzawani B.","family":"Buang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artemis","family":"Papadaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Candice L.","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talat H.","family":"Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Medjeral-Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damiola","family":"Pinheiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paige M.","family":"Mortimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanice","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleanor","family":"Sandhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen P.","family":"McAdoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7048-7457","authenticated-orcid":false,"given":"Maria F.","family":"Prendecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Willicombe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1153-0192","authenticated-orcid":false,"given":"Matthew C.","family":"Pickering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1458-3791","authenticated-orcid":false,"given":"Marina","family":"Botto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9738-2329","authenticated-orcid":false,"given":"David C.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9415-3440","authenticated-orcid":false,"given":"James E.","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,15]]},"reference":[{"key":"35454_CR1","doi-asserted-by":"publisher","first-page":"eabd6197","DOI":"10.1126\/sciimmunol.abd6197","volume":"5","author":"ER Mann","year":"2020","unstructured":"Mann, E. R. et al. Longitudinal immune profiling reveals key myeloid signatures associated with COVID-19. Sci. Immunol. 5, eabd6197 (2020).","journal-title":"Sci. Immunol."},{"key":"35454_CR2","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1038\/s41591-020-1038-6","volume":"26","author":"AG Laing","year":"2020","unstructured":"Laing, A. G. et al. A dynamic COVID-19 immune signature includes associations with poor prognosis. Nat. Med. 26, 1623\u20131635 (2020).","journal-title":"Nat. Med."},{"key":"35454_CR3","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/s41591-021-01329-2","volume":"27","author":"E Stephenson","year":"2021","unstructured":"Stephenson, E. et al. Single-cell multi-omics analysis of the immune response in COVID-19. Nat. Med. 27, 904\u2013916 (2021).","journal-title":"Nat. Med."},{"key":"35454_CR4","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1016\/j.immuni.2020.11.017","volume":"53","author":"JP Bernardes","year":"2020","unstructured":"Bernardes, J. P. et al. Longitudinal multi-omics analyses identify responses of megakaryocytes, erythroid cells, and plasmablasts as hallmarks of severe COVID-19. Immunity 53, 1296\u20131314.e9 (2020).","journal-title":"Immunity"},{"key":"35454_CR5","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.immuni.2021.03.005","volume":"54","author":"PA Szabo","year":"2021","unstructured":"Szabo, P. A. et al. Longitudinal profiling of respiratory and systemic immune responses reveals myeloid cell-driven lung inflammation in severe COVID-19. Immunity 54, 797\u2013814.e6 (2021).","journal-title":"Immunity"},{"key":"35454_CR6","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/j.immuni.2021.05.010","volume":"54","author":"L Bergamaschi","year":"2021","unstructured":"Bergamaschi, L. et al. Longitudinal analysis reveals that delayed bystander CD8+ T cell activation and early immune pathology distinguish severe COVID-19 from mild disease. Immunity 54, 1257\u20131275.e8 (2021).","journal-title":"Immunity"},{"key":"35454_CR7","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1016\/j.cell.2022.01.012","volume":"185","author":"DJ Ahern","year":"2022","unstructured":"Ahern, D. J. et al. A blood atlas of COVID-19 defines hallmarks of disease severity and specificity. Cell 185, 916\u2013938.e58 (2022).","journal-title":"Cell"},{"key":"35454_CR8","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1016\/j.cell.2020.10.037","volume":"183","author":"Y Su","year":"2020","unstructured":"Su, Y. et al. Multi-omics resolves a sharp disease-state shift between mild and moderate COVID-19. Cell 183, 1479\u20131495.e20 (2020).","journal-title":"Cell"},{"key":"35454_CR9","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/s41587-021-01020-4","volume":"40","author":"JW Lee","year":"2022","unstructured":"Lee, J. W. et al. Integrated analysis of plasma and single immune cells uncovers metabolic changes in individuals with COVID-19. Nat. Biotechnol. 40, 110\u2013120 (2022).","journal-title":"Nat. Biotechnol."},{"key":"35454_CR10","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1016\/j.cell.2021.01.053","volume":"184","author":"X Ren","year":"2021","unstructured":"Ren, X. et al. COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas. Cell 184, 1895\u20131913.e19 (2021).","journal-title":"Cell"},{"key":"35454_CR11","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.cell.2022.01.014","volume":"185","author":"Y Su","year":"2022","unstructured":"Su, Y. et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell 185, 881\u2013895.e20 (2022).","journal-title":"Cell"},{"key":"35454_CR12","doi-asserted-by":"publisher","first-page":"100287","DOI":"10.1016\/j.xcrm.2021.100287","volume":"2","author":"MR Filbin","year":"2021","unstructured":"Filbin, M. R. et al. Longitudinal proteomic analysis of severe COVID-19 reveals survival-associated signatures, tissue-specific cell death, and cell-cell interactions. Cell Rep. Med. 2, 100287 (2021).","journal-title":"Cell Rep. Med."},{"key":"35454_CR13","doi-asserted-by":"publisher","unstructured":"Gisby, J. et al. Longitudinal proteomic profiling of dialysis patients with COVID-19 reveals markers of severity and predictors of death. Elife 10, 2020.11.05.20223289 (2021) https:\/\/doi.org\/10.7554\/eLife.64827.","DOI":"10.7554\/eLife.64827"},{"key":"35454_CR14","doi-asserted-by":"publisher","first-page":"100078","DOI":"10.1016\/j.xcrm.2020.100078","volume":"1","author":"L Rodriguez","year":"2020","unstructured":"Rodriguez, L. et al. Systems-level immunomonitoring from acute to recovery phase of severe COVID-19. Cell Rep. Med. 1, 100078 (2020).","journal-title":"Cell Rep. Med."},{"key":"35454_CR15","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.cels.2021.05.005","volume":"12","author":"V Demichev","year":"2021","unstructured":"Demichev, V. et al. A time-resolved proteomic and prognostic map of COVID-19. Cell Syst. 12, 780\u2013794.e7 (2021).","journal-title":"Cell Syst."},{"key":"35454_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23494-1","volume":"12","author":"C Gutmann","year":"2021","unstructured":"Gutmann, C. et al. SARS-CoV-2 RNAemia and proteomic trajectories inform prognostication in COVID-19 patients admitted to intensive care. Nat. Commun. 12, 3406 (2021).","journal-title":"Nat. Commun."},{"key":"35454_CR17","doi-asserted-by":"publisher","first-page":"e65508","DOI":"10.7554\/eLife.65508","volume":"10","author":"MD Galbraith","year":"2021","unstructured":"Galbraith, M. D. et al. Seroconversion stages COVID19 into distinct pathophysiological states. Elife 10, e65508 (2021).","journal-title":"Elife"},{"key":"35454_CR18","doi-asserted-by":"publisher","unstructured":"Paranjpe, I. et al. Proteomic characterization of acute kidney injury in patients hospitalized with SARS-CoV2 Infection. medRxiv 2021.12.09.21267548 (2021) https:\/\/doi.org\/10.1101\/2021.12.09.21267548.","DOI":"10.1101\/2021.12.09.21267548"},{"key":"35454_CR19","doi-asserted-by":"publisher","unstructured":"Su, C.-Y. et al. Circulating proteins to predict adverse COVID-19 outcomes. medRxiv 2021.10.04.21264015 (2021) https:\/\/doi.org\/10.1101\/2021.10.04.21264015.","DOI":"10.1101\/2021.10.04.21264015"},{"key":"35454_CR20","doi-asserted-by":"publisher","unstructured":"Sullivan, K. D. et al. The COVIDome Explorer researcher portal. Cell Rep. 36, (2021) https:\/\/doi.org\/10.1016\/j.celrep.2021.109527.","DOI":"10.1016\/j.celrep.2021.109527"},{"key":"35454_CR21","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJMoa2021436","volume":"384","author":"P Horby","year":"2021","unstructured":"Horby, P. et al. Dexamethasone in hospitalized patients with Covid-19. N. Engl. J. Med. 384, 693\u2013704 (2021).","journal-title":"N. Engl. J. Med."},{"key":"35454_CR22","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1056\/NEJMoa2100433","volume":"384","author":"AC Gordon","year":"2021","unstructured":"Gordon, A. C. et al. Interleukin-6 receptor antagonists in critically Ill patients with Covid-19. N. Engl. J. Med. 384, 1491\u20131502 (2021).","journal-title":"N. Engl. J. Med."},{"key":"35454_CR23","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1016\/S0140-6736(21)00676-0","volume":"397","author":"O Abani","year":"2021","unstructured":"Abani, O. et al. Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet 397, 1637\u20131645 (2021).","journal-title":"Lancet"},{"key":"35454_CR24","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1056\/NEJMoa2031994","volume":"384","author":"AC Kalil","year":"2021","unstructured":"Kalil, A. C. et al. Baricitinib plus Remdesivir for hospitalized adults with Covid-19. N. Engl. J. Med. 384, 795\u2013807 (2021).","journal-title":"N. Engl. J. Med."},{"key":"35454_CR25","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41586-020-2521-4","volume":"584","author":"EJ Williamson","year":"2020","unstructured":"Williamson, E. J. et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature 584, 430\u2013436 (2020).","journal-title":"Nature"},{"key":"35454_CR26","first-page":"2094","volume":"36","author":"E Goffin","year":"2021","unstructured":"Goffin, E. et al. COVID-19-related mortality in kidney transplant and haemodialysis patients: a comparative, prospective registry-based study. Nephrol. Dial. Transplant. Publ. Eur. Dial. Transpl. Assoc. - Eur. Ren. Assoc. 36, 2094\u20132105 (2021).","journal-title":"Nephrol. Dial. Transplant. Publ. Eur. Dial. Transpl. Assoc. - Eur. Ren. Assoc."},{"key":"35454_CR27","doi-asserted-by":"publisher","first-page":"e2131749","DOI":"10.1001\/jamanetworkopen.2021.31749","volume":"4","author":"J-J Chen","year":"2021","unstructured":"Chen, J.-J. et al. Immunogenicity rates after SARS-CoV-2 vaccination in people with end-stage kidney disease: a systematic review and meta-analysis. JAMA Netw. open 4, e2131749 (2021).","journal-title":"JAMA Netw. open"},{"key":"35454_CR28","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1681\/ASN.2021050611","volume":"32","author":"S Anand","year":"2021","unstructured":"Anand, S. et al. Antibody response to COVID-19 vaccination in patients receiving dialysis. J. Am. Soc. Nephrol. 32, 2435\u20132438 (2021).","journal-title":"J. Am. Soc. Nephrol."},{"key":"35454_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2007-8-4-r54","volume":"8","author":"M Blangiardo","year":"2007","unstructured":"Blangiardo, M. & Richardson, S. Statistical tools for synthesizing lists of differentially expressed features in related experiments. Genome Biol. 8, R54 (2007).","journal-title":"Genome Biol."},{"key":"35454_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann, S., Castelo, R. & Guinney, J. GSVA: gene set variation analysis for microarray and RNA-Seq data. BMC Bioinforma. 14, 7 (2013).","journal-title":"BMC Bioinforma."},{"key":"35454_CR31","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1038\/s41591-020-0944-y","volume":"26","author":"AJ Wilk","year":"2020","unstructured":"Wilk, A. J. et al. A single-cell atlas of the peripheral immune response in patients with severe COVID-19. Nat. Med. 26, 1070\u20131076 (2020).","journal-title":"Nat. Med."},{"key":"35454_CR32","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/s41564-021-00884-1","volume":"6","author":"G Liu","year":"2021","unstructured":"Liu, G. et al. ISG15-dependent activation of the sensor MDA5 is antagonized by the SARS-CoV-2 papain-like protease to evade host innate immunity. Nat. Microbiol. 6, 467\u2013478 (2021).","journal-title":"Nat. Microbiol."},{"key":"35454_CR33","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.3389\/fimmu.2020.01372","volume":"11","author":"MY Hachim","year":"2020","unstructured":"Hachim, M. Y. et al. Interferon-induced transmembrane protein (IFITM3) is upregulated explicitly in SARS-CoV-2 infected lung epithelial cells. Front. Immunol. 11, 1372 (2020).","journal-title":"Front. Immunol."},{"key":"35454_CR34","doi-asserted-by":"publisher","unstructured":"Langfelder, P. & Horvath, S. WGCNA: An R package for weighted correlation network analysis. BMC Bioinformatics 9, (2008) https:\/\/doi.org\/10.1186\/1471-2105-9-559.","DOI":"10.1186\/1471-2105-9-559"},{"key":"35454_CR35","doi-asserted-by":"publisher","unstructured":"Velten, B., Braunger, J. M., Arnol, D., Argelaguet, R. & Stegle, O. Identifying temporal and spatial patterns of variation from multi-modal data using MEFISTO. bioRxiv 2020.11.03.366674 (2020) https:\/\/doi.org\/10.1101\/2020.11.03.366674.","DOI":"10.1101\/2020.11.03.366674"},{"key":"35454_CR36","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s00011-022-01545-7","volume":"71","author":"Z Bagheri-Hosseinabadi","year":"2022","unstructured":"Bagheri-Hosseinabadi, Z., Abbasi, M., Kahnooji, M., Ghorbani, Z. & Abbasifard, M. The prognostic value of S100A calcium binding protein family members in predicting severe forms of COVID-19. Inflamm. Res. 71, 369\u2013376 (2022).","journal-title":"Inflamm. Res."},{"key":"35454_CR37","doi-asserted-by":"publisher","unstructured":"Mathew, D. et al. Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications. Science 369, (2020) https:\/\/doi.org\/10.1126\/science.abc8511.","DOI":"10.1126\/science.abc8511"},{"key":"35454_CR38","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1016\/j.cell.2020.08.002","volume":"182","author":"A Silvin","year":"2020","unstructured":"Silvin, A. et al. Elevated calprotectin and abnormal myeloid cell subsets discriminate severe from mild COVID-19. Cell 182, 1401\u20131418.e18 (2020).","journal-title":"Cell"},{"key":"35454_CR39","doi-asserted-by":"publisher","first-page":"6290","DOI":"10.1172\/JCI140335","volume":"130","author":"I S\u00e1nchez-Cerrillo","year":"2020","unstructured":"S\u00e1nchez-Cerrillo, I. et al. COVID-19 severity associates with pulmonary redistribution of CD1c+ DCs and inflammatory transitional and nonclassical monocytes. J. Clin. Invest. 130, 6290\u20136300 (2020).","journal-title":"J. Clin. Invest."},{"key":"35454_CR40","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1056\/NEJMra1909094","volume":"385","author":"G Schett","year":"2021","unstructured":"Schett, G., McInnes, I. B. & Neurath, M. F. Reframing immune-mediated inflammatory diseases through signature cytokine hubs. N. Engl. J. Med. 385, 628\u2013639 (2021).","journal-title":"N. Engl. J. Med."},{"key":"35454_CR41","doi-asserted-by":"publisher","unstructured":"Shilts, J. et al. LRRC15 mediates an accessory interaction with the SARS-CoV-2 spike protein. bioRxiv 2021.09.25.461776 (2021) https:\/\/doi.org\/10.1101\/2021.09.25.461776.","DOI":"10.1101\/2021.09.25.461776"},{"key":"35454_CR42","doi-asserted-by":"publisher","unstructured":"Song, J. et al. LRRC15 is an inhibitory receptor blocking SARS-CoV-2 spike-mediated entry in trans. bioRxiv: the preprint server for biology (2021) https:\/\/doi.org\/10.1101\/2021.11.23.469714.","DOI":"10.1101\/2021.11.23.469714"},{"key":"35454_CR43","doi-asserted-by":"publisher","unstructured":"Loo, L. et al. LRRC15 suppresses SARS-CoV-2 infection and controls collagen production. bioRxiv (2021) https:\/\/doi.org\/10.1101\/2021.11.09.467981.","DOI":"10.1101\/2021.11.09.467981"},{"key":"35454_CR44","doi-asserted-by":"publisher","unstructured":"Ng, J. H. et al. Outcomes of patients with end-stage kidney disease hospitalized with COVID-19. Kidney Int. (2020) https:\/\/doi.org\/10.1016\/j.kint.2020.07.030.","DOI":"10.1016\/j.kint.2020.07.030"},{"key":"35454_CR45","doi-asserted-by":"publisher","first-page":"95005","DOI":"10.18632\/oncotarget.21887","volume":"8","author":"Q Mei","year":"2017","unstructured":"Mei, Q. et al. Regulation of DNA replication-coupled histone gene expression. Oncotarget 8, 95005\u201395022 (2017).","journal-title":"Oncotarget"},{"key":"35454_CR46","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1038\/ncb1903","volume":"11","author":"RK Singh","year":"2009","unstructured":"Singh, R. K., Kabbaj, M.-H. M., Paik, J. & Gunjan, A. Histone levels are regulated by phosphorylation and ubiquitylation-dependent proteolysis. Nat. Cell Biol. 11, 925\u2013933 (2009).","journal-title":"Nat. Cell Biol."},{"key":"35454_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.52","volume":"8","author":"E Silk","year":"2017","unstructured":"Silk, E., Zhao, H., Weng, H. & Ma, D. The role of extracellular histone in organ injury. Cell Death Dis. 8, e2812 (2017).","journal-title":"Cell Death Dis."},{"key":"35454_CR48","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/s41586-020-2332-7","volume":"583","author":"D Bojkova","year":"2020","unstructured":"Bojkova, D. et al. Proteomics of SARS-CoV-2-infected host cells reveals therapy targets. Nature 583, 469\u2013472 (2020).","journal-title":"Nature"},{"key":"35454_CR49","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/s41586-021-03610-3","volume":"594","author":"Y Finkel","year":"2021","unstructured":"Finkel, Y. et al. SARS-CoV-2 uses a multipronged strategy to impede host protein synthesis. Nature 594, 240\u2013245 (2021).","journal-title":"Nature"},{"key":"35454_CR50","doi-asserted-by":"publisher","first-page":"e1001271","DOI":"10.1371\/journal.ppat.1001271","volume":"7","author":"R Vlahos","year":"2011","unstructured":"Vlahos, R. et al. Inhibition of Nox2 oxidase activity ameliorates Influenza A virus-induced lung inflammation. PLOS Pathog. 7, e1001271 (2011).","journal-title":"PLOS Pathog."},{"key":"35454_CR51","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/cdd.2012.167","volume":"20","author":"PA Lang","year":"2013","unstructured":"Lang, P. A. et al. Reactive oxygen species delay control of lymphocytic choriomeningitis virus. Cell Death Differ. 20, 649\u2013658 (2013).","journal-title":"Cell Death Differ."},{"key":"35454_CR52","doi-asserted-by":"publisher","unstructured":"Randzavola, L. O. et al. EROS-mediated control of NOX2 and P2X7 biosynthesis. bioRxiv 2021.09.14.460103 (2021) https:\/\/doi.org\/10.1101\/2021.09.14.460103.","DOI":"10.1101\/2021.09.14.460103"},{"key":"35454_CR53","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1038\/s12276-020-00531-5","volume":"52","author":"B Ng","year":"2020","unstructured":"Ng, B., Cook, S. A. & Schafer, S. Interleukin-11 signaling underlies fibrosis, parenchymal dysfunction, and chronic inflammation of the airway. Exp. Mol. Med. 52, 1871\u20131878 (2020).","journal-title":"Exp. Mol. Med."},{"key":"35454_CR54","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/nature24676","volume":"552","author":"S Schafer","year":"2017","unstructured":"Schafer, S. et al. IL-11 is a crucial determinant of cardiovascular fibrosis. Nature 552, 110\u2013115 (2017).","journal-title":"Nature"},{"key":"35454_CR55","doi-asserted-by":"publisher","first-page":"622468","DOI":"10.3389\/fimmu.2020.622468","volume":"11","author":"K Kiernan","year":"2020","unstructured":"Kiernan, K. & MacIver, N. J. The role of the Adipokine leptin in immune cell function in health and disease. Front. Immunol. 11, 622468 (2020).","journal-title":"Front. Immunol."},{"key":"35454_CR56","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7827-6-17","volume":"6","author":"SE Segerer","year":"2008","unstructured":"Segerer, S. E. et al. The glycoprotein-hormones activin A and inhibin A interfere with dendritic cell maturation. Reprod. Biol. Endocrinol. 6, 17 (2008).","journal-title":"Reprod. Biol. Endocrinol."},{"key":"35454_CR57","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1084\/jem.20170277","volume":"216","author":"M Rapp","year":"2019","unstructured":"Rapp, M. et al. CCL22 controls immunity by promoting regulatory T cell communication with dendritic cells in lymph nodes. J. Exp. Med. 216, 1170\u20131181 (2019).","journal-title":"J. Exp. Med."},{"key":"35454_CR58","doi-asserted-by":"publisher","unstructured":"Zhang, Q. et al. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science 370, (2020) https:\/\/doi.org\/10.1126\/science.abd4570.","DOI":"10.1126\/science.abd4570"},{"key":"35454_CR59","doi-asserted-by":"publisher","unstructured":"Bastard, P. et al. Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science 370, (2020) https:\/\/doi.org\/10.1126\/science.abd4585.","DOI":"10.1126\/science.abd4585"},{"key":"35454_CR60","doi-asserted-by":"publisher","first-page":"e1700067","DOI":"10.1002\/prca.201700067","volume":"12","author":"A Christensson","year":"2018","unstructured":"Christensson, A. et al. The impact of the glomerular filtration rate on the human plasma proteome. Proteom. Clin. Appl. 12, e1700067 (2018).","journal-title":"Proteom. Clin. Appl."},{"key":"35454_CR61","doi-asserted-by":"publisher","first-page":"e016463","DOI":"10.1161\/JAHA.120.016463","volume":"9","author":"J Yang","year":"2020","unstructured":"Yang, J. et al. Impact of kidney function on the blood proteome and on protein cardiovascular risk biomarkers in patients with stable coronary heart disease. J. Am. Heart Assoc. 9, e016463 (2020).","journal-title":"J. Am. Heart Assoc."},{"key":"35454_CR62","doi-asserted-by":"publisher","first-page":"e0212060","DOI":"10.1371\/journal.pone.0212060","volume":"14","author":"L Lind","year":"2019","unstructured":"Lind, L. et al. Longitudinal effects of aging on plasma proteins levels in older adults - associations with kidney function and hemoglobin levels. PLoS ONE 14, e0212060 (2019).","journal-title":"PLoS ONE"},{"key":"35454_CR63","first-page":"606","volume":"25","author":"U Naseeb","year":"2015","unstructured":"Naseeb, U. et al. Complementary LC-MS\/MS proteomic analysis of uremic plasma proteins. J. Coll. Physicians Surg. Pak. 25, 606\u2013609 (2015).","journal-title":"J. Coll. Physicians Surg. Pak."},{"key":"35454_CR64","first-page":"39","volume":"17","author":"IC Macdougall","year":"2002","unstructured":"Macdougall, I. C. & Cooper, A. C. Erythropoietin resistance: the role of inflammation and pro-inflammatory cytokines. Nephrol. Dial. Transplant. Publ. Eur. Dial. Transpl. Assoc. - Eur. Ren. Assoc. 17, 39\u201343 (2002). Suppl 1.","journal-title":"Nephrol. Dial. Transplant. Publ. Eur. Dial. Transpl. Assoc. - Eur. Ren. Assoc."},{"key":"35454_CR65","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1182\/blood-2003-07-2617","volume":"103","author":"P Minoo","year":"2004","unstructured":"Minoo, P., Zadeh, M. M., Rottapel, R., Lebrun, J.-J. & Ali, S. A novel SHP-1\/Grb2-dependent mechanism of negative regulation of cytokine-receptor signaling: contribution of SHP-1 C-terminal tyrosines in cytokine signaling. Blood 103, 1398\u20131407 (2004).","journal-title":"Blood"},{"key":"35454_CR66","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.xkme.2020.05.001","volume":"2","author":"HH Shah","year":"2020","unstructured":"Shah, H. H., Uppal, N. N. & Fishbane, S. Inflammation and erythropoiesis-stimulating agent hyporesponsiveness: a critical connection. Kidney Med. 2, 245\u2013247 (2020).","journal-title":"Kidney Med."},{"key":"35454_CR67","doi-asserted-by":"crossref","unstructured":"Karaboyas, A. et al. Inflammation and Erythropoiesis-Stimulating Agent Response in Hemodialysis Patients: A Self-matched Longitudinal Study of Anemia Management in the Dialysis Outcomes and Practice Patterns Study (DOPPS. Kidney Med 2, 286\u2013296 (2020).","DOI":"10.1016\/j.xkme.2020.01.007"},{"key":"35454_CR68","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1111\/ajt.15369","volume":"19","author":"C Cantarelli","year":"2019","unstructured":"Cantarelli, C., Angeletti, A. & Cravedi, P. Erythropoietin, a multifaceted protein with innate and adaptive immune modulatory activity. Am. J. Transplant. J. Am. Soc. Transplant. Am. Soc. Transpl. Surg. 19, 2407\u20132414 (2019).","journal-title":"Am. J. Transplant. J. Am. Soc. Transplant. Am. Soc. Transpl. Surg."},{"key":"35454_CR69","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1016\/j.mayocp.2021.07.002","volume":"96","author":"FK Ho","year":"2021","unstructured":"Ho, F. K. et al. Thromboembolic risk in hospitalized and nonhospitalized COVID-19 patients: a self-controlled case series analysis of a nationwide cohort. Mayo Clin. Proc. 96, 2587\u20132597 (2021).","journal-title":"Mayo Clin. Proc."},{"key":"35454_CR70","doi-asserted-by":"crossref","unstructured":"Gorog, D. A. et al. Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium. Nat. Rev. Cardiol. 1\u201321 (2022)","DOI":"10.1038\/s41569-021-00665-7"},{"key":"35454_CR71","doi-asserted-by":"publisher","unstructured":"Katsoularis, I. et al. Risks of deep vein thrombosis, pulmonary embolism, and bleeding after covid-19: nationwide self-controlled cases series and matched cohort study. BMJ 377, (2022) https:\/\/doi.org\/10.1136\/bmj-2021-069590.","DOI":"10.1136\/bmj-2021-069590"},{"key":"35454_CR72","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1056\/NEJMoa2104840","volume":"384","author":"A Greinacher","year":"2021","unstructured":"Greinacher, A. et al. Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination. N. Engl. J. Med. 384, 2092\u20132101 (2021).","journal-title":"N. Engl. J. Med."},{"key":"35454_CR73","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1056\/NEJMoa2104882","volume":"384","author":"NH Schultz","year":"2021","unstructured":"Schultz, N. H. et al. Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination. N. Engl. J. Med. 384, 2124\u20132130 (2021).","journal-title":"N. Engl. J. Med."},{"key":"35454_CR74","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1182\/blood.2021013231","volume":"138","author":"A Greinacher","year":"2021","unstructured":"Greinacher, A. et al. Insights in ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia. Blood 138, 2256\u20132268 (2021).","journal-title":"Blood"},{"key":"35454_CR75","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/s41587-020-0439-x","volume":"38","author":"PA Ewels","year":"2020","unstructured":"Ewels, P. A. et al. The nf-core framework for community-curated bioinformatics pipelines. Nat. Biotechnol. 38, 276\u2013278 (2020).","journal-title":"Nat. Biotechnol."},{"key":"35454_CR76","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/nbt.3820","volume":"35","author":"P Di Tommaso","year":"2017","unstructured":"Di Tommaso, P. et al. Nextflow enables reproducible computational workflows. Nat. Biotechnol. 35, 316\u2013319 (2017).","journal-title":"Nat. Biotechnol."},{"key":"35454_CR77","unstructured":"Andrews, S. et al. FastQC: a quality control tool for high throughput sequence data. (2012)."},{"key":"35454_CR78","doi-asserted-by":"crossref","unstructured":"Martin, M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet.journal; Vol 17, No 1 Next Gener. Seq. Data Anal. - 10.14806\/ej.17.1.200 (2011).","DOI":"10.14806\/ej.17.1.200"},{"key":"35454_CR79","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"35454_CR80","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","volume":"31","author":"S Anders","year":"2015","unstructured":"Anders, S., Pyl, P. T. & Huber, W. HTSeq\u2013a Python framework to work with high-throughput sequencing data. Bioinformatics 31, 166\u2013169 (2015).","journal-title":"Bioinformatics"},{"key":"35454_CR81","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139\u2013140 (2010).","journal-title":"Bioinformatics"},{"key":"35454_CR82","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2010-11-3-r25","volume":"11","author":"MD Robinson","year":"2010","unstructured":"Robinson, M. D. & Oshlack, A. A scaling normalization method for differential expression analysis of RNA-seq data. Genome Biol. 11, R25 (2010).","journal-title":"Genome Biol."},{"key":"35454_CR83","doi-asserted-by":"publisher","first-page":"D884","DOI":"10.1093\/nar\/gkaa942","volume":"49","author":"KL Howe","year":"2021","unstructured":"Howe, K. L. et al. Ensembl 2021. Nucleic Acids Res. 49, D884\u2013D891 (2021).","journal-title":"Nucleic Acids Res."},{"key":"35454_CR84","doi-asserted-by":"publisher","first-page":"D939","DOI":"10.1093\/nar\/gkaa980","volume":"49","author":"S Tweedie","year":"2021","unstructured":"Tweedie, S. et al. Genenames.org: the HGNC and VGNC resources in 2021. Nucleic Acids Res. 49, D939\u2013D946 (2021).","journal-title":"Nucleic Acids Res."},{"key":"35454_CR85","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-58766-1","volume":"10","author":"CR John","year":"2020","unstructured":"John, C. R. et al. M3C: Monte Carlo reference-based consensus clustering. Sci. Rep. 10, 1\u201314 (2020).","journal-title":"Sci. Rep."},{"key":"35454_CR86","doi-asserted-by":"publisher","first-page":"1260419","DOI":"10.1126\/science.1260419","volume":"347","author":"M Uhlen","year":"2015","unstructured":"Uhlen, M. et al. Tissue-based map of the human proteome. Sci. (80-.) 347, 1260419\u20131260419 (2015).","journal-title":"Sci. (80-.)"},{"key":"35454_CR87","doi-asserted-by":"crossref","unstructured":"Bates, D., M\u00e4chler, M., Bolker, B. & Walker, S. Fitting Linear Mixed-Effects Models Using lme4. J. Stat. Softw. 67, (2015)","DOI":"10.18637\/jss.v067.i01"},{"key":"35454_CR88","doi-asserted-by":"crossref","unstructured":"Kuznetsova, A., Brockhoff, P. B. & Christensen, R. H. B. lmerTest package: tests in linear mixed effects models. J. Stat. Softw. 82, (2017)","DOI":"10.18637\/jss.v082.i13"},{"key":"35454_CR89","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1093\/bioinformatics\/btaa687","volume":"37","author":"GE Hoffman","year":"2021","unstructured":"Hoffman, G. E. & Roussos, P. Dream: powerful differential expression analysis for repeated measures designs. Bioinformatics 37, 192\u2013201 (2021).","journal-title":"Bioinformatics"},{"key":"35454_CR90","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-016-1323-z","volume":"17","author":"GE Hoffman","year":"2016","unstructured":"Hoffman, G. E. & Schadt, E. E. variancePartition: interpreting drivers of variation in complex gene expression studies. BMC Bioinforma. 17, 483 (2016).","journal-title":"BMC Bioinforma."},{"key":"35454_CR91","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1093\/bioinformatics\/btr260","volume":"27","author":"A Liberzon","year":"2011","unstructured":"Liberzon, A. et al. Molecular signatures database (MSigDB) 3.0. Bioinformatics 27, 1739\u20131740 (2011).","journal-title":"Bioinformatics"},{"key":"35454_CR92","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22312-y","volume":"12","author":"N Buang","year":"2021","unstructured":"Buang, N. et al. Type I interferons affect the metabolic fitness of CD8+ T cells from patients with systemic lupus erythematosus. Nat. Commun. 12, 1980 (2021).","journal-title":"Nat. Commun."},{"key":"35454_CR93","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1093\/bioinformatics\/btr709","volume":"28","author":"R Kolde","year":"2012","unstructured":"Kolde, R., Laur, S., Adler, P. & Vilo, J. Robust rank aggregation for gene list integration and meta-analysis. Bioinformatics 28, 573\u2013580 (2012).","journal-title":"Bioinformatics"},{"key":"35454_CR94","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-18705-z","volume":"8","author":"J Li","year":"2018","unstructured":"Li, J. et al. Application of weighted gene co-expression network analysis for data from paired design. Sci. Rep. 8, 622 (2018).","journal-title":"Sci. Rep."},{"key":"35454_CR95","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fpsyg.2017.00456","volume":"8","author":"JZ Bakdash","year":"2017","unstructured":"Bakdash, J. Z. & Marusich, L. R. Repeated measures correlation. Front. Psychol. 8, 1\u201313 (2017).","journal-title":"Front. Psychol."},{"key":"35454_CR96","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1093\/bioinformatics\/btm563","volume":"24","author":"P Langfelder","year":"2008","unstructured":"Langfelder, P., Zhang, B. & Horvath, S. Defining clusters from a hierarchical cluster tree: the Dynamic Tree Cut package for R. Bioinformatics 24, 719\u2013720 (2008).","journal-title":"Bioinformatics"},{"key":"35454_CR97","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12874-019-0666-3","volume":"19","author":"A Perperoglou","year":"2019","unstructured":"Perperoglou, A., Sauerbrei, W., Abrahamowicz, M. & Schmid, M. A review of spline function procedures in R. BMC Med. Res. Methodol. 19, 1\u201316 (2019).","journal-title":"BMC Med. Res. Methodol."},{"key":"35454_CR98","first-page":"100141","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu, T. et al. clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innov 2, 100141 (2021).","journal-title":"Innov"},{"key":"35454_CR99","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41587-019-0114-2","volume":"37","author":"AM Newman","year":"2019","unstructured":"Newman, A. M. et al. Determining cell type abundance and expression from bulk tissues with digital cytometry. Nat. Biotechnol. 37, 773\u2013782 (2019).","journal-title":"Nat. Biotechnol."},{"key":"35454_CR100","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman, A. M. et al. Robust enumeration of cell subsets from tissue expression profiles. Nat. Methods 12, 453\u2013457 (2015).","journal-title":"Nat. Methods"},{"key":"35454_CR101","doi-asserted-by":"crossref","unstructured":"Velten, B. et al. Identifying temporal and spatial patterns of variation from multimodal data using MEFISTO. Nat. Methods 19, (2022)","DOI":"10.1038\/s41592-021-01343-9"},{"key":"35454_CR102","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v028.i05","volume":"28","author":"M Kuhn","year":"2008","unstructured":"Kuhn, M. Building predictive models in R using the caret package. J. Stat. Softw. 28, 1\u201326 (2008).","journal-title":"J. Stat. Softw."},{"key":"35454_CR103","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v033.i01","volume":"33","author":"JH Friedman","year":"2010","unstructured":"Friedman, J. H., Hastie, T. & Tibshirani, R. Regularization paths for generalized linear models via coordinate descent. J. Stat. Softw. 33, 1\u201322 (2010).","journal-title":"J. Stat. Softw."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-35454-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-35454-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-35454-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T17:09:01Z","timestamp":1671124141000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-35454-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,15]]},"references-count":103,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["35454"],"URL":"https:\/\/doi.org\/10.1038\/s41467-022-35454-4","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,15]]},"assertion":[{"value":"29 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"None of the authors have any patents (planned, pending or issued) or competing interests relevant to this work. Other interests unrelated to this work: S.P.M. reports personal fees from Celltrion, Rigel, GSK and Cello; M.C.P. reports consulting honoraria with Alexion, Apellis, Achillion, Novartis and Gyroscope; D.C.T. reports speaker and consultancy fees from Astra-Zeneca and Novartis; J.E.P. has received travel and accommodation expenses and hospitality from Olink proteomics to speak at Olink-sponsored academic meetings (none within the past 5 years). None of the other authors have any interests to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7775"}}